NCT06296056View on ClinicalTrials.gov

Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

May 28, 2025

Study Completion Date

June 8, 2025

Conditions
Solid TumorsMetastatic
Interventions
BIOLOGICAL

Combi

Biological immune cell therapy

Trial Locations (1)

Unknown

Seoul Hospital, Ulaanbaatar

All Listed Sponsors
lead

Seoul Hospital

OTHER

NCT06296056 - Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi) | Biotech Hunter | Biotech Hunter